Morphine Sulfate Wockhardt Uk

Morphine Sulfate, the active ingredient in Morphine Sulfate Wockhardt Uk, is an opioid analgesic presented as an oral dosage form for oral use. It provides potent analgesia for patients experiencing moderate to severe pain and is classified as a Schedule II controlled substance for acute, postoperative, and cancer‑related pain management.

GNH USA supplies Morphine Sulfate Wockhardt Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, ensuring quality and regulatory compliance across all markets.

Morphine Sulfate is an opioid analgesic used to manage pain across several clinical contexts.

- Moderate to severe acute pain: provides rapid analgesia for injuries or surgical procedures - Postoperative pain: reduces pain following operative interventions - Cancer‑related pain: alleviates persistent severe pain associated with malignancies

Morphine sulfate may cause a range of adverse reactions, varying from mild to potentially life‑threatening.

Common Side Effects: - Nausea - Constipation - Drowsiness or sedation - Dizziness - Sweating - Dry mouth

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Addiction, dependence, or withdrawal syndrome - Anaphylactic or severe allergic reactions - Adrenal insufficiency

When prescribing morphine sulfate, clinicians should observe several safety considerations to minimize risk.

- Assess pain severity and opioid tolerance: determine appropriate starting dose - Monitor respiratory function: watch for depression especially after dose changes - Evaluate hepatic and renal function: adjust dose in impairment - Avoid concomitant CNS depressants: increase risk of sedation and respiratory depression - Educate patients on dependence and withdrawal: discuss signs and safe use - Store at room temperature: keep in original container, protect from moisture and light

Morphine sulfate can interact with other medicines, altering its effect or safety profile.

Major Interactions (Avoid): - Benzodiazepines or other CNS depressants: additive respiratory depression - Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension or serotonin syndrome - Other potent respiratory depressants (e.g., barbiturates, propofol): profound respiratory suppression

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): increase morphine plasma levels - SSRIs or SNRIs: potential serotonin syndrome - Anticholinergic agents: may exacerbate constipation - Alcohol: enhances sedative effects